Age related Macular degeneration is a disease that causes damage to the macular, the center of the retina, causing various visual symptoms. The macula is densely packed with endoscopic retinal cells and is responsible for 90% of vision, including central vision and color discrimination. When degeneration occurs in this area, symptoms begin with symptoms that make objects appear crushed or bent straight, and can eventually lead to blindness

It has the effect of suppressing angiogenesis by reducing the expression rate of VEGF and PEDF

Treatment that improves retinal function and relieves edema by inhibiting new blood vessels in the choroid of patients with age-related macular degeneration and has proven effectiveness and safety of an ophthalmic preparation that can overcome disadvantages such as invasive drug administration and high treatment costs of antibody drugs